Skip to main content
. 2020 Nov 10;12:207–215. doi: 10.2147/DHPS.S257009

Figure 1.

Figure 1

Flowchart of this study.

Note: Data from Pharmaceuticals and Medical Devices Agency.  ADR information for eculizumab from the first quarter of 2010 to the second quarter of 2019. Available from: (https://www.pmda.go.jp/safety/info-services/drugs/adr-info/suspected-adr/0003.html).19 See materials and methods section for detail.